Jennifer Spiegel in Paso Robles, California

Medical School: University Of Kansas School Of Med (kc/wich/sal)
Graduation Year: 2009
The Primary Medical Specialty for Jennifer Spiegel is listed as: Ophthalmology
Approximate Years of Experience: 15
PAC (PECOS ID)#: 6305087248
NPI #: 1912136938
NPI Created On: 07/12/2009
NPI Last Updated Listed as: 08/17/2017
Primary Taxonomy Code: 207W00000X
License Number:
A134733
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Korean, Farsi.

Services and Procedures include:

1. Injection of drug into eye
2. Removal of membrane from the retina, pars plana approach
3. Repair of detached retina and drainage of eye fluid between lens and retina
4. Preventive retinal detachment treatment by heat or laser, 1 or more sessions
5. Laser destruction of leaking retinal blood vessels, 1 or more sessions
6. Ultrasound of eye disease, growth, or structure
7. Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits
8. Eye and medical examination for diagnosis and treatment, established patient
9. Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits
10. Measurement of field of vision during daylight conditions
11. Diagnostic imaging of retina
12. Imaging of blood vessels in back of eye using fluorescein dye
13. Photography of the retina
14. Established patient office or other outpatient visit, typically 15 minutes
15. Established patient office or other outpatient, visit typically 25 minutes
16. Chronic care management services at least 20 minutes per calendar month
17. Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 fo
18. Injection, aflibercept, 1 mg
19. Injection, bevacizumab, 10 mg